Aims-To compare proliferating cell nuclear antigen (PCNA) and MIB-1 with bromodeoxyuridine (BrdU) pulse labelling, a specific marker of cell proliferation, in endoscopic gastric biopsy specimens. Methods-Twenty four biopsy specimens were obtained from 12 patients: 10 antral and eight body specimens were suitable. Each specimen was routinely processed and stained with haematoxylin and eosin. A modified Giemsa stain was used to detect the presence of Helicobacter pyloni. Sections of the specimens were labelled with BrdU, MIB-1, and PC1O. Gastric mucosa specimens were divided into three zones. The numbers of positively staining nuclei for 500 epithelial cell nuclei were counted in each zone and expressed as a percentage. Results-The proportion of PCNA positive cells (range 0-90%) was much greater in all specimens (10 antrum, eight body). BrdU positive cells were virtually all confined to zone 2 (0-17% cells in this zone were positive) (zone 1 = surface and gastric pit, zone 2 = isthmus, zone 3 = gland base), while PCNA positive cells were present in all three zones (1 = 23-90%, 2 = 43-90%, 3 = 0-74%). Spearman's rank coefficient correlation of 0l57 confirmed that the percentage of positively staining cells varied in the same direction for both PCNA and BrdU (p < 0 001). PCNA, however, was overexpressed in all zones of the gastric epithelium compared with BrdU. In 38 biopsy specimens from 19 patients, of which 14 antrum and 11 body were suitable, the proportion of MIB-1 positive cells (0-59%) was greater than BrdU in most. As with BrdU labelling, the MIB-1 positive cells were confined to zone 2 (zone 1 = 1-11%); zone 2 = 21-59%; zone 3 = 0-13%) and the coefficient correlation for MIB-1 and BrdU was 0-63
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Conclusions-MIB-1 accurately reflects the S-phase fraction in gastric mucosa, determined by BrdU labelling in conventionally processed gastric biopsy material. Caution is needed in the interpretation of PCNA labelling detected by PCIO, which should not be accepted uncritically as a marker of cell proliferation in paraffin wax embedded material. Gastric epithelium exists in a state of equilibrium between cell proliferation in the gastric pits and cell loss into the lumen. This state is influenced by both physiological and pathological processes. Gastric mucosal biopsy specimens provide "snapshots" of the mucosa, and labelling with a marker of cell proliferation allows the proliferative activity of the epithelium in various disease states to be compared. The use of flexible endoscopy has produced a large archive of biopsy material which could be studied with a cell proliferation marker designed for use on routinely processed, paraffin wax embedded material.
Proliferating cell nuclear antigen (PCNA) is a 36 kilodalton DNA polymerase 6 auxiliary protein essential for DNA synthesis. It is associated with the cell cycle.' 2 PC10 is a monoclonal antibody directed to genetically engineered PCNA and has been reported as a marker of cell proliferation suitable for use on conventionally fixed and processed normal human tissue.3 MIB-1 is one of three recombinant monoclonal antibodies reactive to parts of the Ki-67 antigen.4 The monoclonal antibody Ki67 reacts with a human nuclear cell proliferation associated antigen that is expressed in all active parts of the cell cycle and is well established as a marker of cell proliferation.5 6 The main disadvantage of the Ki-67 method is that fresh frozen material is required. Recently MIB-1 has been reported to stain a true Ki-67 equivalent using immunostaining techniques on frozen sections. Poor results were obtained initially on conventionally fixed and processed biopsy material, but heating the dewaxed sections in a microwave oven prior to immunostaining produced strong nuclear staining of proliferating cells. 4 It is important to compare a new technique with a recognised standard to assess its suitability as a measurement of cell proliferation. Bromodeoxyuridine (BrdU), a thymidine analogue, can be incorporated into the cell cycle during S phase (DNA synthesis). Immunohistochemical techniques using an antibody to BrdU on tissues exposed to it either in vivo or in vitro, produce a marker of cell proliferation which is regarded as a "gold standard". Comparison oflabelling by BrdU, MIB-1, and PCNA in gastnic biopsy specimens 16 This relatively long half-life leads to its expression in cells which have left the cell cycle and are therefore not synthesising DNA. This is in con-NA trast to Ki-67 which is expressed in the active rhe parts of the cell cycle-G1, S, G2 and mitoto sis, but not GO. The overexpression of PC10 the is said to be particularly prominent in formared, lin fixed tissue, but in the study of PCNA in 1 in rat gastric mucosa and rat mammary tumours "S-methacarn was used as the fixative and, in an spite of this precaution, similar high concencell trations of the protein were found. ' Comparison oflabelling by BrdU, MIB-1, and PCNA in gastric biopsy specimens promote PCNA expression may be present in the stomach but absent in the colon. Whatever the reason for the high PC I0 expression in the stomach, our finding of up to 90% positivity in normal gastric epithelium leaves very little room for the detection of increased cell turnover in disease states.
Methods
In conclusion, MIB-1 immunostaining of conventionally fixed and processed gastric mucosal biopsy specimens, following incubation in a microwave oven, correlates closely with that of BrdU labelling, and may be used as a method of determining cell proliferation in these. In contrast, PCNA, as detected by PC 10, does not accurately reflect the S-phase fraction in gastric mucosa, as determined by BrdU labelling. In view of all the factors already known to influence PC10 labelling, extreme caution is needed in its interpretation, and it should not be accepted uncritically as a marker of cell proliferation in paraffin wax embedded material.
